{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04932",
    "Peptide Name": "NP-1 2b analog (Synthetic AMPs, Arg-rich,  2S=S, UCBB1a)",
    "Source": "circularization, amino acid SUBSTITUTION, defensin analog, animal-derived, natural derivatives",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "VVGACRRALGLPRERRAGFCRIRGRIHPLGGRR",
    "Sequence Length": 33,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+",
      "Gram-",
      "Antifungal",
      "candidacidal"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 10,
    "Boman Index": 3.37,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "39%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (87.88%) toRabbit neutrophil peptide 1 NP-1R: 30%; G: 18%.Activity: low salt, active against E. coli (MIC 1.6 ug/ml), S. typhimurium (MIC 2.0 ug/ml), P. aeruginosa (MIC 2.5 ug/ml), K. pneumoniae (MIC 2.5 ug/ml), L. monocytogenes (MIC 1.8 ug/ml), and C. albicans (MIC 19.9 ug/ml).Antimicrobial robustness: NaCl-insensitive:E. coli (100 mM), NaCl-sensitive:S. typhimurium (100 mM), NaCl-insensitive:P. aeruginosa (100 mM), NaCl-sensitive:K. pneumoniae (100 mM), NaCl-insensitive:L. monocytogenes (100 mM), NaCl-sensitive:C. albicans (100 mM).In vitro toxicity: human RBC, not hemo.lytic (HC50 3188 ug/ml).",
    "Author": "Yu Q, Lehrer RI, Tam JP.2000",
    "Reference": "J Biol Chem. 2000 Feb 11;275(6):3943-9. doi: 10.1074/jbc.275.6.3943.PubMed",
    "Title": "Engineered salt-insensitive alpha-defensins with end-to-end circularized structures"
  },
  "3D Structure": []
}